CoChat

Gamma-aminobutyric acid-producing lactobacilli positively affect metabolism and depressive-like behaviour in a mouse model of metabolic syndrome

Open access

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

Abstract

Metabolic and neuroactive metabolite production represents one of the mechanisms through which the gut microbiota can impact health. One such metabolite, gamma-aminobutyric acid (GABA), can modulate glucose homeostasis and alter behavioural patterns in the host. We previously demonstrated that oral administration of GABA-producing Lactobacillus brevis DPC6108 has the potential to increase levels of circulating insulin in healthy rats. Therefore, the objective of this study was to assess the efficacy of endogenous microbial GABA production in improving metabolic and behavioural outcomes in a mouse model of metabolic dysfunction. Diet-induced obese and metabolically dysfunctional mice received one of two GABA-producing strains, L . brevis DPC6108 or L . brevis DSM32386, daily for 12 weeks. After 8 and 10 weeks of intervention, the behavioural and metabolic profiles of the mice were respectively assessed. Intervention with both L . brevis strains attenuated several abnormalities associated with metabolic dysfunction, causing a reduction in the accumulation of mesenteric adipose tissue, increased insulin secretion following glucose challenge, improved plasma cholesterol clearance and reduced despair-like behaviour and basal corticosterone production during the forced swim test. Taken together, this exploratory dataset indicates that intervention with GABA-producing lactobacilli has the potential to improve metabolic and depressive- like behavioural abnormalities associated with metabolic syndrome in mice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-019-51781-x

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 L. brevis reduced fat mass and distribution of adiposity after 12 weeks of intervention. (A) Schematic figure representing mouse trial design and timeline for procedures, with high-fat diet represented by the black arrow and treatments in a 12-week intervention represented by coloured arrows. (B) Bodyweight gain throughout the pre-feeding (white background) and intervention (red background) for n = 14 mice per group. (C) Adipose tissue mass and distribution across EAT, SAT and MAT and (D) Fat and lean body composition. (E) Final body weight after 24-week feeding (HFC; n = 13 and LFC; n = 10) and 12-week intervention with DPC6108 (n = 14) and DSM32386 (n = 14). Data are expressed as mean ± SEM. Bodyweight data were analysed using the mixed model ANOVA. Tukey’s post-hoc test was applied. All other data were analysed using the appropriate unpaired student t-test (HFC vs LFC) and one-way analysis of variance (ANOVA). ###p < 0.001 HFC vs LFC, *p < 0.05 treatment vs HFC, and **p < 0.01 treatment vs HFC. IP-GTT: intraperitoneal glucose tolerance test, IP-ITT: insulin tolerance test, EPM: elevated plus maze, FST: forced swim test, OF: open field, NOR: novel object recognition, MMG: mixed meal gavage, NMR: nuclear magnetic resonance, HFC: high fat control, DPC6108: L. brevis DPC6108, DSM32386: L. brevis DSM32386, LFC: low fat control, EAT: epididymal adipose tissue, SAT: subcutaenous adipose tissue and MAT: mesenteric adipose tissue. Figure 1A was created with BioRender.com.
Figure 1 L. brevis reduced fat mass and distribution of adiposity after 12 weeks of intervention. (A) Schematic figure representing mouse trial design and timeline for procedures, with high-fat diet represented by the black arrow and treatments in a 12-week intervention represented by coloured arrows. (B) Bodyweight gain throughout the pre-feeding (white background) and intervention (red background) for n = 14 mice per group. (C) Adipose tissue mass and distribution across EAT, SAT and MAT and (D) Fat and lean body composition. (E) Final body weight after 24-week feeding (HFC; n = 13 and LFC; n = 10) and 12-week intervention with DPC6108 (n = 14) and DSM32386 (n = 14). Data are expressed as mean ± SEM. Bodyweight data were analysed using the mixed model ANOVA. Tukey’s post-hoc test was applied. All other data were analysed using the appropriate unpaired student t-test (HFC vs LFC) and one-way analysis of variance (ANOVA). ###p < 0.001 HFC vs LFC, *p < 0.05 treatment vs HFC, and **p < 0.01 treatment vs HFC. IP-GTT: intraperitoneal glucose tolerance test, IP-ITT: insulin tolerance test, EPM: elevated plus maze, FST: forced swim test, OF: open field, NOR: novel object recognition, MMG: mixed meal gavage, NMR: nuclear magnetic resonance, HFC: high fat control, DPC6108: L. brevis DPC6108, DSM32386: L. brevis DSM32386, LFC: low fat control, EAT: epididymal adipose tissue, SAT: subcutaenous adipose tissue and MAT: mesenteric adipose tissue. Figure 1A was created with BioRender.com.CC BY · PubMed Central
Figure 2 L. brevis DSM32386 improved glucose clearance in the IP-GTT while both strains improved glucose-dependent insulin secretion following glucose challenge in the IP-ITT. HFC (n = 7) and LFC (n = 7) mice were assessed for 1 g/Kg glucose (IP-GTT; A,B) and 0.75 IU/Kg insulin (IP-ITT; C,D) glycaemic responses following 12 weeks of feeding, prior to commencement of treatments at week 13. At week 24 of feeding and after 10 weeks of intervention, LFC (n = 7), HFC (n = 7), DPC6108 (n = 14), and DSM32386 (n = 14) mice were assessed for glycaemic responses to glucose (E,F) and insulin (G,H) challenges. Plasma insulin concentration as determined from samples collected at T = 0 and T = 15 during glucose challenge for LFC (n = 7), HFC (n = 5), DPC6108 (n = 14) and DSM32386 (n = 12) (I) and insulin resistance index determined by multiplying the area under the curve of both the blood glucose (0 to 120 min) and the plasma insulin (0 to 15 min) obtained following glucose challenge (J). At week 24 of feeding and after 10 weeks of intervention LFC (n = 7), HFC (n = 7), DPC6108 (n = 14), DSM32386 (n = 14) mice were assessed for cholesterol metabolism by oral gavage with a complete meal, Ensure Plus, Abbott Nutrition. Total plasma cholesterol was measured at T = 0, T = 2, T = 4 and T18 hr post-gavage (K). Total AUC for cholesterol metabolism was calculated from individual time points for all groups (L). Data are expressed as mean ± SEM. All data was analysed using the appropriate unpaired student t-test (HFC vs LFC) and one-way analysis of variance (ANOVA). #p < 0.001 HFC vs LFC, ##p < 0.001 HFC vs LFC and ###p < 0.001 HFC vs LFC, *p < 0.05 treatment vs HFC, **p < 0.01 treatment vs HFC and ***p < 0.001 treatment vs HFC. AUC: area under curve, HFC: high fat control, DPC6108: L. brevis DPC6108, DSM32386: L. brevis DSM32386, LFC: low fat control.
Figure 2 L. brevis DSM32386 improved glucose clearance in the IP-GTT while both strains improved glucose-dependent insulin secretion following glucose challenge in the IP-ITT. HFC (n = 7) and LFC (n = 7) mice were assessed for 1 g/Kg glucose (IP-GTT; A,B) and 0.75 IU/Kg insulin (IP-ITT; C,D) glycaemic responses following 12 weeks of feeding, prior to commencement of treatments at week 13. At week 24 of feeding and after 10 weeks of intervention, LFC (n = 7), HFC (n = 7), DPC6108 (n = 14), and DSM32386 (n = 14) mice were assessed for glycaemic responses to glucose (E,F) and insulin (G,H) challenges. Plasma insulin concentration as determined from samples collected at T = 0 and T = 15 during glucose challenge for LFC (n = 7), HFC (n = 5), DPC6108 (n = 14) and DSM32386 (n = 12) (I) and insulin resistance index determined by multiplying the area under the curve of both the blood glucose (0 to 120 min) and the plasma insulin (0 to 15 min) obtained following glucose challenge (J). At week 24 of feeding and after 10 weeks of intervention LFC (n = 7), HFC (n = 7), DPC6108 (n = 14), DSM32386 (n = 14) mice were assessed for cholesterol metabolism by oral gavage with a complete meal, Ensure Plus, Abbott Nutrition. Total plasma cholesterol was measured at T = 0, T = 2, T = 4 and T18 hr post-gavage (K). Total AUC for cholesterol metabolism was calculated from individual time points for all groups (L). Data are expressed as mean ± SEM. All data was analysed using the appropriate unpaired student t-test (HFC vs LFC) and one-way analysis of variance (ANOVA). #p < 0.001 HFC vs LFC, ##p < 0.001 HFC vs LFC and ###p < 0.001 HFC vs LFC, *p < 0.05 treatment vs HFC, **p < 0.01 treatment vs HFC and ***p < 0.001 treatment vs HFC. AUC: area under curve, HFC: high fat control, DPC6108: L. brevis DPC6108, DSM32386: L. brevis DSM32386, LFC: low fat control.CC BY · PubMed Central
Figure 3 L. brevis increased GABA levels in small intestinal content. GABA levels were determined from tissue samples collected at the end of the 12-week intervention from LFC (n = 8), HFC (n = 12), DPC6108 (n = 14), DSM32386 (n = 11) from epididymal adipose tissue (A) and from LFC (n = 10), HFC (n = 12), DPC6108 (n = 14), DSM32386 (n = 14) in total small intestinal content (B). Data are expressed as mean ± SEM. All data was analysed using the appropriate unpaired student t-test (HFC vs LFC) and one-way analysis of variance (ANOVA). ###p < 0.001 HFC vs LFC, **p < 0.01 treatment vs HFC. AUC: area under curve, GABA: gamma-aminobutyric acid, HFC: high fat control, DPC6108: L. brevis DPC6108, DSM32386: L. brevis DSM32386, LFC: low fat control.
Figure 3 L. brevis increased GABA levels in small intestinal content. GABA levels were determined from tissue samples collected at the end of the 12-week intervention from LFC (n = 8), HFC (n = 12), DPC6108 (n = 14), DSM32386 (n = 11) from epididymal adipose tissue (A) and from LFC (n = 10), HFC (n = 12), DPC6108 (n = 14), DSM32386 (n = 14) in total small intestinal content (B). Data are expressed as mean ± SEM. All data was analysed using the appropriate unpaired student t-test (HFC vs LFC) and one-way analysis of variance (ANOVA). ###p < 0.001 HFC vs LFC, **p < 0.01 treatment vs HFC. AUC: area under curve, GABA: gamma-aminobutyric acid, HFC: high fat control, DPC6108: L. brevis DPC6108, DSM32386: L. brevis DSM32386, LFC: low fat control.CC BY · PubMed Central
Figure 4 L. brevis altered plasma ornithine and arginine. (A) Sparse partial least square discriminant analysis (sPLS-DA) plot displays HFC (n = 10; red), DPC6108 (n = 10; green) and DSM32386 (n = 10; purple) samples. (B) Plot metabolite loadings graph displaying key metabolite differences between groups. Quantitative data is displayed for the metabolites which were significantly altered by DPC6108 or DSM32386; this included the biogenic amine ornithine (C) and amino acid arginine (D). Orn:Ornithine, Arg:Arginine, Met-SO:Methioninesulfoxide, Glu:Glutamate, alpha AAA:alpha Aminoadipic Acid, Met:Methionine, Phe:Phenylalanine, Gln:Glutamine, HFC: high fat control, DPC6108: L. brevis DPC6108, DSM32386: L. brevis DSM32386. *q < 0.05 treatment vs HFC, **q < 0.01 treatment vs HFC. Plots depict individual replicates with mean and SEM.
Figure 4 L. brevis altered plasma ornithine and arginine. (A) Sparse partial least square discriminant analysis (sPLS-DA) plot displays HFC (n = 10; red), DPC6108 (n = 10; green) and DSM32386 (n = 10; purple) samples. (B) Plot metabolite loadings graph displaying key metabolite differences between groups. Quantitative data is displayed for the metabolites which were significantly altered by DPC6108 or DSM32386; this included the biogenic amine ornithine (C) and amino acid arginine (D). Orn:Ornithine, Arg:Arginine, Met-SO:Methioninesulfoxide, Glu:Glutamate, alpha AAA:alpha Aminoadipic Acid, Met:Methionine, Phe:Phenylalanine, Gln:Glutamine, HFC: high fat control, DPC6108: L. brevis DPC6108, DSM32386: L. brevis DSM32386. *q < 0.05 treatment vs HFC, **q < 0.01 treatment vs HFC. Plots depict individual replicates with mean and SEM.CC BY · PubMed Central
Figure 5 Both diet and L. brevis had a significant impact on gut microbiota composition. Relative abundance of microbial taxa at (A) phylum and (B) genus level. Phyla and genera representing <0.1% abundance in any sample were considered as Other. The PCA plot based on OTU relative abundances of the bacterial community and the metabolic parameters measured in mice (C). The first two principal coordinates (PC1 and PC2) are plotted for each sample (D), with the variables related to the variance between groups. PCA: Principal Component Analysis, OTU; Operational Taxonomy Unit.
Figure 5 Both diet and L. brevis had a significant impact on gut microbiota composition. Relative abundance of microbial taxa at (A) phylum and (B) genus level. Phyla and genera representing <0.1% abundance in any sample were considered as Other. The PCA plot based on OTU relative abundances of the bacterial community and the metabolic parameters measured in mice (C). The first two principal coordinates (PC1 and PC2) are plotted for each sample (D), with the variables related to the variance between groups. PCA: Principal Component Analysis, OTU; Operational Taxonomy Unit.CC BY · PubMed Central
Figure 6 L. brevis improved symptoms of depression-like behaviour in the FST and resting corticosterone levels. The effect of HF-diet feeding and L. brevis intervention on depression-like behaviour and the HPA axis response to stress was assessed after 21 weeks of feeding and after 8 weeks of intervention. Despair behaviour was assessed thorough immobility time (A) by mice throughout the test and anxiety-like behaviour was assessed through the number of faecal pellets produced during the test (B). Plasma isolated at T = 0, just prior to the FST was used to measure corticosterone production (C) and subsequent plasma samples collected at T = 15, T = 45, T = 90 and T = 120 post-FST were used to calculate corticosterone as a measure of the HPA axis response to stress (D). Samples were collected from mice in LFC (n = 13), HFC (n = 12), DPC6108 (n = 11), DSM32386 (n = 14). All data was analysed using the appropriate unpaired student t-test (HFC vs LFC) and one-way analysis of variance (ANOVA). #p < 0.05 HFC vs LFC, ##p < 0.01 HFC vs LFC and ###p < 0.001 HFC vs LFC, **p < 0.01 treatment vs HFC and ***p < 0.001 treatment vs HFC. FST: forced swim test, HF: high fat, HFC: high fat control, HPA: hypothalamic pituitary adrenal, DPC6108: L. brevis DPC6108, DSM32386: L. brevis DSM32386, LFC: low fat control.
Figure 6 L. brevis improved symptoms of depression-like behaviour in the FST and resting corticosterone levels. The effect of HF-diet feeding and L. brevis intervention on depression-like behaviour and the HPA axis response to stress was assessed after 21 weeks of feeding and after 8 weeks of intervention. Despair behaviour was assessed thorough immobility time (A) by mice throughout the test and anxiety-like behaviour was assessed through the number of faecal pellets produced during the test (B). Plasma isolated at T = 0, just prior to the FST was used to measure corticosterone production (C) and subsequent plasma samples collected at T = 15, T = 45, T = 90 and T = 120 post-FST were used to calculate corticosterone as a measure of the HPA axis response to stress (D). Samples were collected from mice in LFC (n = 13), HFC (n = 12), DPC6108 (n = 11), DSM32386 (n = 14). All data was analysed using the appropriate unpaired student t-test (HFC vs LFC) and one-way analysis of variance (ANOVA). #p < 0.05 HFC vs LFC, ##p < 0.01 HFC vs LFC and ###p < 0.001 HFC vs LFC, **p < 0.01 treatment vs HFC and ***p < 0.001 treatment vs HFC. FST: forced swim test, HF: high fat, HFC: high fat control, HPA: hypothalamic pituitary adrenal, DPC6108: L. brevis DPC6108, DSM32386: L. brevis DSM32386, LFC: low fat control.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 73 references

Cited by

See all 186

Metadata

Authors
Patterson, E., Ryan, P. M., Wiley, N., Carafa, I., Sherwin, E., Moloney, G., Franciosi, E., Mandal, R., Wishart, D. S., Tuohy, K., Ross, R. P., Cryan, J. F., Dinan, T. G., & Stanton, C.
Affiliations
  • Teagasc - The Irish Agriculture and Food Development Authority (IE)
  • Fondazione Edmund Mach (IT)
  • University College Cork (IE)
  • University of Alberta (CA)
Corresponding author
Stanton, C.
Venue
Scientific Reports
Published
2019-11-08
Volume
9
Issue
1
Pages
16323-16323
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2984278771
Cited by
168
References
72
Citations by year
2026: 8 · 2025: 21 · 2024: 35 · 2023: 38 · 2022: 26 · 2021: 32 · 2020: 8
FWCI
12.73
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Arrow@dit (Dublin Institute of Technology) (acceptedVersion)
  • CINECA IRIS Institutional Research Information System (Fondazione Edmund Mach) (submittedVersion, cc-by)
  • HAL (submittedVersion)
  • Cork Open Research Archive (University College Cork, Ireland) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • T-Stór (Teagasc) (submittedVersion, cc-by-nc-sa)
  • Open Research (University of Surrey) (submittedVersion, cc-by)
Funders
  • Ireland Canada University Foundation
  • University of Alberta
  • Science Foundation Ireland (SFI/12/RC/, 12/RC/2273, 12/RC/, SFI/12/RC/2273.)
  • Teagasc
  • University College Cork
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › GABA and Rice Research
Keywords
GABA, Lactobacillus brevis, metabolic syndrome, diet-induced obesity, gut microbiota, depression-like behavior, insulin secretion, glucose homeostasis, mesenteric adipose tissue, corticosterone, forced swim test, neuroactive metabolites
MeSH terms
Adipose Tissue, Animals, Behavior, Animal, Body Weight, Cholesterol, Corticosterone, Depression, Disease Models, Animal, gamma-Aminobutyric Acid, Gastrointestinal Transit, Glucose, Insulin Resistance, Intestine, Small, Maze Learning, Metabolic Syndrome, Mice, Levilactobacillus brevis, Metabolomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gamma-aminobutyric acid-producing lactobacilli positively affect metabolism and depressive-like behaviour in a mouse model of metabolic syndrome. https://app.cochat.ai/papers/10.1038/s41598-019-51781-x
The paper
Patterson, E., Ryan, P. M., Wiley, N., Carafa, I., Sherwin, E., Moloney, G., Franciosi, E., Mandal, R., Wishart, D. S., Tuohy, K., Ross, R. P., Cryan, J. F., Dinan, T. G., & Stanton, C. (2019). Gamma-aminobutyric acid-producing lactobacilli positively affect metabolism and depressive-like behaviour in a mouse model of metabolic syndrome. Scientific Reports. https://doi.org/10.1038/s41598-019-51781-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.